Showing results (311-320 of 332) with videos related to
Sort By:
Pageof 34
United European Gastroenterology Journal|February 29, 2024
Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international studyMariangela Allocca, Gaia Catalano, Edoardo V Savarino, et al.Inflammatory Bowel Diseases|June 8, 2017
Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective StudyUri Kopylov, Konstantinos Papamichael, Konstantinos Katsanos, et al.Journal of Crohn'S & Colitis|March 11, 2025
Definitions, diagnosis, and management of postoperative recurrence in Crohn's disease patients with permanent ileostomy-a systematic review and meta-analysisSuha Abushamma, Tesfaye Yadete, Neil Nero, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 12, 2025
Janus kinase (JAK) inhibitor-induced acne in inflammatory bowel disease - an international, multicenter, retrospective cohort studySailish Honap, Maria José Temido, Eathar Shakweh, et al.The Lancet. Gastroenterology & Hepatology|January 20, 2022
Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel DiseasesLucas Guillo, Maria Abreu, Remo Panaccione, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 21, 2022
IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL ConsensusBénédicte Caron, Maria T Abreu, Corey A Siegel, et al.Inflammatory Bowel Diseases|November 21, 2013
Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohortJohan Burisch, Natalia Pedersen, Silvja Cukovic-Cavka, et al.Journal of Crohn'S & Colitis|June 10, 2025
The effectiveness of second- and-third-line biologics in perianal Crohn's disease-a multicenter propensity score-matched studyUria Shani, Monica State, Radu Bogdan Mateescu, et al.European Journal of Gastroenterology & Hepatology|August 23, 2018
Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD studyStefania Chetcuti Zammit, Pierre Ellul, Giulia Girardin, et al.Journal of Crohn'S & Colitis|November 20, 2019
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical TreatmentMichel Adamina, Stefanos Bonovas, Tim Raine, et al.Pageof 34